6 research outputs found
THE DYNAMICS OF HAEMOSTATIC PARAMETERS IN ACUTE PSYCHOTIC PATIENTS: A ONE-YEAR PROSPECTIVE STUDY
Background: The primary goal of the present study was to replicate our previous finding of increased coagulation and
thrombocytes activity in drug-naĂŻve psychotic patients in comparison with healthy controls and ascertain whether the blood levels of
thrombogenesis markers further increase over the course of a consecutive one-year antipsychotic treatment.
Subjects and methods: We investigated the plasma levels of markers indicating activation of coagulation (D-dimers and Factor
VIII) and platelets (soluble P-selectin, sP-selectin) in an antipsychotic-naive group of nineteen men and seventeen women with acute
psychosis (age 28.1±8.0 years, body mass index 22.6±4.2), and thirty-seven healthy volunteers matched for age, gender and body
mass index. In the patient group, we repeated these assessments after three months and again after one year of antipsychotic
treatment.
Results: D-dimers (median 0.38 versus 0.19 mg/l; p=0.00008), factor VIII (median 141.5% versus 110%; p=0.02) and sPselectin
(median 183.6 versus 112.4 ng/ml; p=0.00005) plasma levels were significantly increased in the group of patients with acute
psychosis prior to treatment compared with healthy volunteers. The plasma levels of sP-selectin varied significantly (p=0.016) in the
course of the one-year antipsychotic treatment, mainly between 3 and 6 months after start of therapy. The plasma levels of D-dimers
and factor VIII did not change significantly, D-dimers remained elevated in contrast to the healthy controls.
Conclusions: Patients with acute psychosis had increased levels of markers of thrombogenesis in comparison to the healthy
volunteers. The haemostatic parameters also remained elevated during the one-year antipsychotic treatment
Markers of thrombogenesis are activated in unmedicated patients with acute psychosis: a matched case control study
<p>Abstract</p> <p>Background</p> <p>Antipsychotic treatment has been repeatedly found to be associated with an increased risk for venous thromboembolism in schizophrenia. The extent to which the propensity for venous thromboembolism is linked to antipsychotic medication alone or psychosis itself is unclear. The objective of this study was to determine whether markers of thrombogenesis are increased in psychotic patients who have not yet been treated with antipsychotic medication.</p> <p>Methods</p> <p>We investigated the plasma levels of markers indicating activation of coagulation (D-dimers and Factor VIII) and platelets (soluble P-selectin, sP-selectin) in an antipsychotic-naive group of fourteen men and eleven women with acute psychosis (age 29.1 ± 8.3 years, body mass index 23.6 ± 4.7), and twenty-five healthy volunteers were matched for age, gender and body mass index.</p> <p>Results</p> <p>D-dimers (median 0.38 versus 0.19 mg/l, mean 1.12 ± 2.38 versus 0.28 ± 0.3 mg/l; P = 0.003) and sP-selectin (median 204.1 versus 112.4 ng/ml, mean 209.9 ± 124 versus 124.1 ± 32; P = 0.0005) plasma levels were significantly increased in the group of patients with acute psychosis as compared with healthy volunteers. We found a trend (median 148% versus 110%, mean 160 ± 72.5 versus 123 ± 62.5; P = 0.062) of increased plasma levels of factor VIII in psychotic patients as compared with healthy volunteers.</p> <p>Conclusions</p> <p>The results suggest that at least a part of venous thromboembolic events in patients with acute psychosis may be induced by pathogenic mechanisms related to psychosis rather than by antipsychotic treatment. Finding an exact cause for venous thromboembolism in psychotic patients is necessary for its effective treatment and prevention.</p
Needs of Hospitalized Schizophrenic Patients in the North Moravia and the Czech Part of Silesia
Objectives: The main aim of the study was to investigate the physiological and social needs of patients hospitalized with schizophrenia to uncover potential issues in these areas. Methods: The relevant self-evaluating CANSAS questionnaire for physiological and social needs was used by nurses in a cohort of hospitalized schizophrenic patients undergoing rehabilitation before discharge from the mental hospital. Results: Two hundred and forty-four patients (women N = 115) aged 18–58 years were involved in the study. Intimate relations, financial matters, treatment of psychotic symptoms, and sexual life were among the most pressing physiological and social needs in our study subjects. Conclusion: The results of our study should stimulate psychiatric nurses in their effort not only to detect but also address the problems of schizophrenic patients concerning unfulfilled needs
Genome‑Wide Association Studies in Schizophrenia, and Potential Etiological and Functional Implications of Their Results
Background: Despite the fact that the genetic basis of schizophrenia has been intensively studied for more than two decades, our contemporary knowledge in this field is rather fractional, and a substantial part of it is still missing. The aim of this review article is to sum up the data coming from genome‑wide association genetic studies in schizophrenia, and indicate prospective directions of further scientific endeavour. Methods: We searched the National Human Genome Research Institute’s Catalog of genome‑wide association studies for schizophrenia to identify all papers related to this topic. In consequence, we looked up the possible relevancy of these findings for etiology and pathogenesis of schizophrenia using the computer gene and PubMed databases. Results: Eighteen genome‑wide association studies in schizophrenia have been published till now, referring to fifty‑seven genes supposedly involved into schizophrenia’s etiopathogenesis. Most of these genes are related to neurodevelopment, neuroendocrinology, and immunology. Conclusions: It is reasonable to predict that complex studies of sufficiently large samples, involving detection of copy number variants and assessment of endophenotypes, will produce definitive discoveries of genetic risk factors for schizophrenia in the future
THE DYNAMICS OF HAEMOSTATIC PARAMETERS IN ACUTE PSYCHOTIC PATIENTS: A ONE-YEAR PROSPECTIVE STUDY
Background: The primary goal of the present study was to replicate our previous finding of increased coagulation and
thrombocytes activity in drug-naĂŻve psychotic patients in comparison with healthy controls and ascertain whether the blood levels of
thrombogenesis markers further increase over the course of a consecutive one-year antipsychotic treatment.
Subjects and methods: We investigated the plasma levels of markers indicating activation of coagulation (D-dimers and Factor
VIII) and platelets (soluble P-selectin, sP-selectin) in an antipsychotic-naive group of nineteen men and seventeen women with acute
psychosis (age 28.1±8.0 years, body mass index 22.6±4.2), and thirty-seven healthy volunteers matched for age, gender and body
mass index. In the patient group, we repeated these assessments after three months and again after one year of antipsychotic
treatment.
Results: D-dimers (median 0.38 versus 0.19 mg/l; p=0.00008), factor VIII (median 141.5% versus 110%; p=0.02) and sPselectin
(median 183.6 versus 112.4 ng/ml; p=0.00005) plasma levels were significantly increased in the group of patients with acute
psychosis prior to treatment compared with healthy volunteers. The plasma levels of sP-selectin varied significantly (p=0.016) in the
course of the one-year antipsychotic treatment, mainly between 3 and 6 months after start of therapy. The plasma levels of D-dimers
and factor VIII did not change significantly, D-dimers remained elevated in contrast to the healthy controls.
Conclusions: Patients with acute psychosis had increased levels of markers of thrombogenesis in comparison to the healthy
volunteers. The haemostatic parameters also remained elevated during the one-year antipsychotic treatment